ITC Ltd, a diversified company, has started clinical studies on nasal spray to prevent Covid-19.
According to insiders, the nasal spray was developed by experts at ITC Life Sciences and Technology Centre (LSTC) in Bengaluru, and the business hopes to offer it under the Savlon brand after it receives all of the necessary regulatory clearances.
When contacted for comments, a spokesperson of ITC said, “We are unable to share more details at the current moment as the clinical trials are underway.”
Clinical Trial Details
There is no official statement regarding the place where the clinical trial is being conducted and under what name the nasal spray will be marketed
They also stated that when used in conjunction with existing hygiene measures advised by health authorities, the device has the potential to be effective and safe in avoiding COVID-19 infection and transmission.
During the pandemic, the company’s R&D teams were essential in developing a variety of new health and hygiene products that were commercially marketed under the Savlon brand.
Demand For Nasal Sprays
Cipla, a pharmaceutical company, released an antiviral nasal spray a month ago.
Glenmark is in the final stages of testing to deliver SaNOtize’s nasal spray to India.
Comments are closed, but trackbacks and pingbacks are open.